Nexthera Capital’s CoLucid Pharmaceuticals CLCD Stock Holding History
Bought
Maintained
Sold
Other funds holding CLCD
Nexthera Capital's CLCD Position: Q4 2016 in Review
Nexthera Capital sold out of CoLucid Pharmaceuticals (CLCD) in Q4 2016, closing a stake of 100,000 shares — an estimated $3.82M sold.
Nexthera Capital first reported a position in CLCD in Q3 2016 and held it in 1 quarter. The position peaked at $3.82M in Q3 2016. 76 funds tracked by Wall St. Rank hold CLCD as of Q4 2016.
- Nexthera Capital reported no remaining CoLucid Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Nexthera Capital sold 100,000 CoLucid Pharmaceuticals shares in Q4 2016, an estimated $3.82M.
- Nexthera Capital first reported a position in CoLucid Pharmaceuticals in Q3 2016 and held it in 1 quarter.
- Nexthera Capital's CoLucid Pharmaceuticals position peaked at $3.82M in Q3 2016.
- 76 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals as of Q4 2016.
Based on Nexthera Capital's 13F filing for Q4 2016, filed 14 Feb 2017.